Ocular myasthenia gravis patients following the administration of tacrolimus and steroids

J Neurol Sci. 2019 Jan 15:396:30-32. doi: 10.1016/j.jns.2018.10.027. Epub 2018 Oct 30.

Authors

Taku Omata¹, Kaori Fukui², Kazuo Kodama³, Yoshimi Watanabe³, Hiromi Aoyama³, Katsunori Fujii⁴, Naoki Shimojo⁴

Affiliations

¹ Division of Child Neurology, Chiba Children's Hospital, Chiba, Japan. Electronic address: takuoma@hotmail.co.jp.
² Division of Child Neurology, Chiba Children's Hospital, Chiba, Japan; Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.
³ Division of Child Neurology, Chiba Children's Hospital, Chiba, Japan.
⁴ Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba, Japan.

PMID: 30399462
DOI: 10.1016/j.jns.2018.10.027

No abstract available

Keywords: Childhood-onset; Myasthenia gravis; Prednisolone; Steroid; Tacrolimus.

Publication types

Letter

MeSH terms

Blepharoptosis / drug therapy
Blepharoptosis / etiology
Child, Preschool
Female
Humans
Immunosuppressive Agents / therapeutic use*
Male
Myasthenia Gravis / complications
Myasthenia Gravis / drug therapy*
Oculomotor Muscles / drug effects*
Oculomotor Muscles / physiopathology*
Prednisolone / therapeutic use
Retrospective Studies
Steroids / therapeutic use*
Tacrolimus / therapeutic use*

Substances

Immunosuppressive Agents
Steroids
Prednisolone
Tacrolimus